{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T09:28:45Z","timestamp":1786786125142,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chengde Science and Technology Plan Project","award":["202303A058"],"award-info":[{"award-number":["202303A058"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07101-1","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:25:07Z","timestamp":1780392307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AML with t(16;21)(p11.2;q22)\/FUS::ERG rearrangement presenting with hemophagocytes and multinucleated cells: a case report and literature review"],"prefix":"10.1007","volume":"105","author":[{"given":"Yingying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"XinhongYang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"11","key":"7101_CR1","first-page":"2865","volume":"54","author":"H Ichikawa","year":"1994","unstructured":"Ichikawa H, Shimizu K, Hayashi Y et al (1994) An RNA-binding protein gene, TLS\/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res 54(11):2865\u20132868","journal-title":"Cancer Res"},{"issue":"4","key":"7101_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/gcc.2870110408","volume":"11","author":"I Panagopoulos","year":"1994","unstructured":"Panagopoulos I, Aman P, Fioretos T et al (1994) Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22). Genes Chromosomes Cancer 11(4):256\u2013262","journal-title":"Genes Chromosomes Cancer"},{"key":"7101_CR3","doi-asserted-by":"crossref","unstructured":"Z Heyang, Z Qianru, W Xiaoxue et al (2022)TLS\/FUS-ERG fusion gene in acute leukemia and myelodysplastic syndrome evolved to acute leukemia: report of six cases and a literature review.Ann Hematol 101(12):2583\u20132600","DOI":"10.1007\/s00277-022-04979-5"},{"issue":"15","key":"7101_CR4","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1182\/blood-2018-05-849059","volume":"132","author":"S Noort","year":"2018","unstructured":"Noort S, Zimmermann M, Reinhardt D et al (2018) Prognostic impact of t(16;21)(p11;q22)and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM study group. Blood 132(15):1584\u20131592","journal-title":"Blood"},{"issue":"7","key":"7101_CR5","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1080\/10428194.2016.1260124","volume":"58","author":"J Pan","year":"2017","unstructured":"Pan J, Zhang Y, Zhao YL, Yang JF, Zhang JP, Liu HX, Wu T, Tong CR (2017) Impact of clinical factors on outcome of leukemia patients with TLS-ERG fusion gene. Leuk Lymphoma 58(7):1655\u20131663","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"7101_CR6","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1038\/leu.2017.126","volume":"31","author":"H Zhang","year":"2017","unstructured":"Zhang H, Reister Schultz A, Luty S et al (2017) Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations. Leukemia 31(12):2752\u20132760","journal-title":"Leukemia"},{"issue":"7","key":"7101_CR7","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/ajh.27340","volume":"99","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Zhuo N, Zhou Y et al (2024) Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients. Am J Hematol 99(7):1441\u20131444","journal-title":"Am J Hematol"},{"issue":"6","key":"7101_CR8","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00277-018-3267-z","volume":"97","author":"E Zerkalenkova","year":"2018","unstructured":"Zerkalenkova E, Panfyorova A, Kazakova A et al (2018) Molecular characteristic of acute leukemias with t(16;21)\/FUS-ERG. Ann Hematol 97(6):977\u2013988","journal-title":"Ann Hematol"},{"issue":"2","key":"7101_CR9","first-page":"90","volume":"43","author":"L Shi","year":"2026","unstructured":"Shi L, Huang S, Xie X et al (2026) Clinical efficacy analysis of seven pediatric patients with Acute myeloid leukemia and the t(16;21)(p11;q22) FUS::ERG fusion gene. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 43(2):90\u201395 (Chinese)","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"7101_CR10","doi-asserted-by":"crossref","unstructured":"Bravo-Davila M, Espinoza-Rodrigez D, Orejon-Huarancca J et al (2026) Characterization of Acute Myeloid Leukemia With t(16;21) Translocation: Cytogenetic,Molecular,and Immunophenotypic Findings.World J Oncol 5;17(2):178\u2013190.","DOI":"10.14740\/wjon2700"},{"key":"7101_CR11","doi-asserted-by":"crossref","unstructured":"Crozat A, Aman P, Mandahl N et al (1993) Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.Nature 17;363(6430):640\u20134","DOI":"10.1038\/363640a0"},{"issue":"12","key":"7101_CR12","first-page":"3717","volume":"9","author":"DD Prasad","year":"1994","unstructured":"Prasad DD, Ouchida M, Lee L et al (1994) TLS\/FUS fusion domain of TLS\/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene 9(12):3717\u20133729","journal-title":"Oncogene"},{"issue":"10","key":"7101_CR13","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1128\/MCB.20.10.3345-3354.2000","volume":"20","author":"L Yang","year":"2000","unstructured":"Yang L, Embree LJ, Hickstein DD (2000) TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins. Mol Cell Biol 20(10):3345\u20133354","journal-title":"Mol Cell Biol"},{"key":"7101_CR14","first-page":"1192","volume":"90","author":"XT Kong","year":"1997","unstructured":"Kong XT, Ida K, Ichikawa H et al (1997) Consistent detection of TLS\/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript. Blood 90:1192\u20131199","journal-title":"Blood"},{"issue":"1","key":"7101_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3343\/alm.2016.36.1.79","volume":"36","author":"I Song","year":"2016","unstructured":"Song I, Lee DH, Lee JH et al (2016) A t(8;9)(p22;p24)\/PCM1-JAK2 translocation in a patient with myeloproliferative neoplasm and myeloid sarcoma: first report in Korea. Ann Lab Med 36(1):79\u201381","journal-title":"Ann Lab Med"},{"key":"7101_CR16","doi-asserted-by":"crossref","unstructured":"Buteyn NJ, LaMantia SJ, Burke CG, et al(2025)EZH2-driven immune evasion at disease presentation defines a targetable high-risk subset of acute leukemia exemplified by t(16;21) FUS::ERG AML. bioRxiv [Preprint] 18:2024.05.14.594150","DOI":"10.1101\/2024.05.14.594150"},{"key":"7101_CR17","doi-asserted-by":"crossref","unstructured":"Sun Yao, Chen Jianlin, Liu Yarong et al (2019) Donor-Derived CD123-Targeted CAR T Cell Serves as a RIC Regimen for Haploidentical Transplantation in a Patient With FUS-ERG+ AML.Front Oncol 3;9:1358","DOI":"10.3389\/fonc.2019.01358"},{"key":"7101_CR18","doi-asserted-by":"crossref","unstructured":"Fan M, Li M, Gao L, Geng S, Wang J, Wang Y, Yan Z, Yu L (2017) Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia. J Hematol Oncol. 29;10(1):151","DOI":"10.1186\/s13045-017-0519-7"},{"issue":"13","key":"7101_CR19","doi-asserted-by":"publisher","first-page":"880108","DOI":"10.3389\/fimmu.2022.880108","volume":"9","author":"H Mu-Mosley","year":"2022","unstructured":"Mu-Mosley H, Ostermann L, Muftuoglu M et al (2022) Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX Models. Front Immunol 9(13):880108","journal-title":"Front Immunol"},{"key":"7101_CR20","doi-asserted-by":"crossref","unstructured":"Lai A, Liu W, Wei H et al(2024)The RTK-RAS signaling pathway is enriched in patients with rare acute myeloid leukemia harboring t(16;21)(p11;q22)\/FUS::ERG. Blood Sci 10;6(2):e00188","DOI":"10.1097\/BS9.0000000000000188"},{"issue":"2","key":"7101_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12185-010-0650-5","volume":"92","author":"DW Jekarl","year":"2010","unstructured":"Jekarl DW, Kim M, Lim J et al (2010) CD56 antigen expression and hemophagocytosis of leukemic cells in acute myeloid leukemia with t(16;21)(p11;q22). Int J Hematol 92(2):306\u2013313","journal-title":"Int J Hematol"},{"key":"7101_CR22","doi-asserted-by":"crossref","unstructured":"Valent, P., K. Sotlar, K. Blatt, K. et al (2017) Proposed diagnostic criteria and classification of basophilic leukemias and related disorders. Leukemia. 31(4):788\u2013797","DOI":"10.1038\/leu.2017.15"},{"key":"7101_CR23","doi-asserted-by":"crossref","unstructured":"Kim J, TS, Park J, Song K et al (2009) Detection of FUS-ERG chimeric transcript in two cases of acute myeloid leukemia with t (16;21)(p11.2;q22) with unusual characteristics. Cancer Genet. Cytogenet. 194:111\u2013118","DOI":"10.1016\/j.cancergencyto.2009.06.010"},{"issue":"12","key":"7101_CR24","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1002\/ccr3.1219","volume":"5","author":"Y Toda","year":"2017","unstructured":"Toda Y, Nagai Y, Shimomura D et al (2017) Acute basophilic leukemia associated with the t(16;21) (p11;q22)\/FUS-ERG fusion gene. Clin Case Rep 5(12):1938\u20131944 (11;)","journal-title":"Clin Case Rep"},{"issue":"11","key":"7101_CR25","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1007\/s00277-023-05382-4","volume":"102","author":"X Huang","year":"2023","unstructured":"Huang X, Li T, Zhang Y et al (2023) Hemophagocytosis by multinucleated leukemic blasts, basophilia, and micromegakaryocytes in AML with TLS::ERG. Ann Hematol 102(11):3279\u20133281","journal-title":"Ann Hematol"},{"key":"7101_CR26","unstructured":"Hu GH, Lu AD, Jia YP et al (2020) Clinical features and prognosis of acute myeloid leukemia with TLS\/ERG positive in children.Lin Chuang Er Ke Za Zhi 38(12):6"},{"issue":"5","key":"7101_CR27","doi-asserted-by":"publisher","DOI":"10.3892\/or.2024.8805","volume":"52","author":"L Chen","year":"2024","unstructured":"Chen L, Zeng P, Tang H et al (2024) Routes and molecular mechanisms of central nervous system involvement in acute myeloid leukemia (review). Oncol Rep 52(5):146","journal-title":"Oncol Rep"},{"key":"7101_CR28","doi-asserted-by":"crossref","unstructured":"Psiachou-Leonard E, Paterakis G, Stefanaki K et al (2001) Cerebellar granulocytic sarcoma in an infant with CD56+ acute monoblastic leukemia.Leuk Res 25(11):1019\u201321","DOI":"10.1016\/S0145-2126(01)00068-6"},{"issue":"21","key":"7101_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1182\/blood.V116.21.184.184","volume":"116","author":"G Kaspers","year":"2010","unstructured":"Kaspers G, Zimmermann M, Reinhardt D et al (2010) Central Nervous System (CNS) involvement in pediatric relapsed acute myeloid leukemia: results and lessons from study Relapsed AML 2001\/01. Blood 116(21):184","journal-title":"Blood"},{"key":"7101_CR30","unstructured":"Vishwanath Anil, Harpreet Gosal, Harsimran Kaur et al (2021) Chronic Neutrophilic Leukemia:A Literature Review of the Rare Myeloproliferative Pathology.Cureus 3;13(6):e15433"},{"key":"7101_CR31","doi-asserted-by":"crossref","unstructured":"Ouyang Y, Qiao C, Chen Y et al (2017) Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia. Oncotarget. 28;8(13):20834\u201320841","DOI":"10.18632\/oncotarget.15355"},{"issue":"18","key":"7101_CR32","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1182\/blood.2019004179","volume":"135","author":"K Tarlock","year":"2020","unstructured":"Tarlock K, Alonzo T, Wang YC et al (2020) Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemia. Blood 135(18):1603\u20131606 (30;)","journal-title":"Blood"},{"issue":"2","key":"7101_CR33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ajh.25688","volume":"95","author":"N Szuber","year":"2020","unstructured":"Szuber N, Elliott M, Tefferi A (2020) Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management. Am J Hematol 95(2):212\u2013224","journal-title":"Am J Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07101-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07101-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07101-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T09:20:31Z","timestamp":1786785631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07101-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["7101"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07101-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8795234\/v1","asserted-by":"object"}]},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical stan dards of the institutional and\/or national research com mittee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","label":"Declarations","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Written informed consent for publication was obtained from the patient.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"352"}}